Home NDC 42571-245 OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE
Product NDC 42571-245
11-digit product format 425710245
Labeler code 42571
Product ID 42571-245_44b62ded-18e8-b2e8-e063-6294a90ac180
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Micro Labs Limited
Application ANDA207437
Marketing category ANDA
Marketing start 2026-03-01
Substance OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Active strength 20; 5; 12.5 mg/1; mg/1; mg/1
Pharmacologic classes Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207437-001 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL EQ 5MG BASE;12.5MG;20MG TABLET / ORAL AB 2025-11-24 A207437-002 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL EQ 5MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 A207437-003 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL EQ 5MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 A207437-004 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL EQ 10MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 A207437-005 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL EQ 10MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A207437-001 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;20MG TABLET / ORAL AB 2025-11-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207437-002 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207437-003 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207437-004 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207437-005 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 A207437-001 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;20MG TABLET / ORAL AB 2025-11-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207437-002 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207437-003 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207437-004 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207437-005 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207437-001 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;20MG TABLET / ORAL AB 2025-11-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207437-002 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207437-003 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207437-004 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207437-005 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207437-001 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;20MG TABLET / ORAL AB 2025-11-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207437-002 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207437-003 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207437-004 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207437-005 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A207437-001 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;20MG TABLET / ORAL AB 2025-11-24 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A207437-002 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A207437-003 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 5MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A207437-004 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;12.5MG;40MG TABLET / ORAL AB 2025-11-24 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A207437-005 OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE EQ 10MG BASE;25MG;40MG TABLET / ORAL AB 2025-11-24 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OLMESARTAN MEDOXOMIL 20 mg/1 AMLODIPINE BESYLATE 5 mg/1 HYDROCHLOROTHIAZIDE 12.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 864V2Q084H Internal UNII lookup 6M97XTV3HD Internal UNII lookup 0J48LPH2TH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 5 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 999967 Internal RxNorm lookup 999986 Internal RxNorm lookup 999991 Internal RxNorm lookup 999996 Internal RxNorm lookup 1000001 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42571-245-05 OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE 500 in 1 BOTTLE TABLET, FILM COATED 500 5 42571-245-10 OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE 1000 in 1 BOTTLE TABLET, FILM COATED 1000 5 42571-245-30 OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE 30 in 1 BOTTLE TABLET, FILM COATED 30 5 42571-245-90 OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE 90 in 1 BOTTLE TABLET, FILM COATED 90 5
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 42571-245-05 42571024505 500 TABLET, FILM COATED in 1 BOTTLE (42571-245-05) 2026-03-01 No No Current 42571-245-10 42571024510 1000 TABLET, FILM COATED in 1 BOTTLE (42571-245-10) 2026-03-01 No No Current 42571-245-30 42571024530 30 TABLET, FILM COATED in 1 BOTTLE (42571-245-30) 2026-03-01 No No Current 42571-245-90 42571024590 90 TABLET, FILM COATED in 1 BOTTLE (42571-245-90) 2026-03-01 No No Current